Page last updated: 2024-12-05

arecaidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10355
CHEMBL ID432561
CHEBI ID2813
SCHEMBL ID336164
MeSH IDM0065165

Synonyms (41)

Synonym
chebi:2813 ,
CHEMBL432561 ,
unii-0s8yev0d4o
0s8yev0d4o ,
arecaine
nsc 76017
1,2,5,6-tetrahydro-1-methylnicotinic acid
nicotinic acid, 1,2,5,6-tetrahydro-1-methyl-
brn 0112366
1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxylic acid
methylguvacine
n-methylguvacine
3-pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-
nsc-76017
nicotinic acid,2,5,6-tetrahydro-1-methyl-
3-pyridinecarboxylic acid,2,5,6-tetrahydro-1-methyl-
NSC76017 ,
C15864
499-04-7
arecaidine
1-methyl-3,6-dihydro-2h-pyridine-5-carboxylic acid
FT-0662272
FT-0662271
bdbm50000107
1-methyl-1,2,5,6-tetrahydro-pyridine-3-carboxylic acid
AKOS004912635
arecaidine [mi]
SCHEMBL336164
methylguvacin
1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid
DNJFTXKSFAMXQF-UHFFFAOYSA-N
1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylic acid #
DTXSID60198139
gtpl9487
1-methyl-5,6-dihydro-2h-pyridine-3-carboxylic acid
1,2,5,6-tetrahydro-1-methyl-nicotinic acid
Q9159393
STL565165
MS-22815
CS-0022549
HY-N2368

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" However, the pharmacokinetic parameters of these compounds have been little explored."( Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers.
Franke, AA; Lai, JF; Li, X, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
" However, the mechanism underlying its oral bioavailability has not yet been studied."( Transport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1).
Brandsch, M; Laug, L; Markwardt, F; Thondorf, I; Voigt, V; Zebisch, K, 2013
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
citraconoyl group
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)IC50 (µMol)694.00000.00071.600310.0000AID143614
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID143614Inhibitory concentration required to inhibit [3H]strychnine binding to N-methyl-D-aspartate glutamate receptor 11992Journal of medicinal chemistry, Jan-24, Volume: 35, Issue:2
Beta-proline analogues as agonists at the strychnine-sensitive glycine receptor.
AID781325pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 20092014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (9.52)18.7374
1990's9 (14.29)18.2507
2000's22 (34.92)29.6817
2010's23 (36.51)24.3611
2020's3 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.32 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index83.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.99%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (97.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]